Meta-analyses of studies on bone marrow micrometastases: An independent prognostic impact remains to be substantiated

Journal of Clinical Oncology

Volumn 16, Issue 2, 1998, Pages 557-566

  Funke, Ilona ^a   Schraut, Winfried ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW METASTASIS; CANCER STAGING; CANCER SURVIVAL; CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; META ANALYSIS; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

EID: 0031953025     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.2.557     Document Type: Article

References (100)

1. Sloane JP, Ormerod MG, Neville AM: Potential pathological application of immmunocytochemical methods to the detection of micrometastases. Cancer Res 40:3079-3082, 1980
2. Berger U, Bettelheim R, Mansi JL, et al: The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am J Clin Pathol 90:1-6, 1988
3. Kirk SJ, Cooper GG, Hoper M, et al: The prognostic significance of marrow micrometastases in women with early breast cancer. Eur J Surg Oncol 16:481-485, 1990
4. Salvadori B, Squicciarini P, Rovini D, et al: Use of monoclonal antibody MBr1 to detect micrometastases in bone marrow specimens of breast cancer patients. Eur J Cancer 26:865-867, 1990
5. Cote RJ, Rosen PP, Lesser M, et al: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9:1749-1756, 1991
6. Dearnaley DP, Ormerod MG, Sloane JP: Micrometastases in breast cancer: Long-term follow-up of the first patient cohort. Eur J Cancer 27:236-239, 1991
7. Mansi JL, Easton D, Berger U, et al: Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-up. Eur J Cancer 27:1552-1555, 1991
8. Singletary SE, Larry L, Tucker S, et al: Detection of micrometastatic tumor cells in bone marrow of breast carcinoma patients. J Surg Oncol 47:32-36, 1991
9. Courtemanche DJ, Worth AJ, Coupland RW, et al: Monoclonal antibody LICR-LON-M8 does not predict the outcome of operable breast cancer. Can J Surg 34:21-26, 1991
10. Harbeck N, Untch M, Pache L: Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: Results of a 3-year median follow-up. Br J Cancer 69:566-571, 1994
11. Diel IJ, Kaufmann M, Costa SD, et al: Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status. J Natl Cancer Inst 88:1652-1664, 1996
12. Molino A, Pelosi G, Turazza M, et al: Bone marrow micrometastases in 109 breast cancer patients: Correlations with clinical and pathological features and prognosis. Breast Cancer Res Treat 42:23-30, 1997
13. Schlimok G, Funke I, Bock B, et al: Epithelial tumor cells in bone marrow of patients with colorectal cancer: Immunocytochemical detection, phenotypic characterization and prognostic significance. J Clin Oncol 8:831-837, 1990
14. Schlimok G, Funke I, Pantel K, et al: Micrometastatic tumour cells in bone marrow of patients with gastric cancer: Methodological aspects of detection and prognostic significance. Eur J Cancer 27:1461-1465, 1991
15. Lindemann F, Schlimok G, Dirschedl P, et al: Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340:685-689, 1992
16. Wollenberg B, Ollesch A, Maag K, et al: Mikrometastasen im Knochenmark von Patienten mit Karzinomen des Kopf-Hals-Bereiches. Laryngo Rhino Otol 73:88-93, 1994
17. Cote RJ, Beattie EJ, Chaiwun B, et al: Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. Ann Surg 222:415-423, 1995
18. Pantel K, Izbicki J, Passlick B, et al: Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 347:649-653, 1996
19. Jauch KW, Heiss MM, Gruetzner U, et al: The prognostic significance of bone marrow micrometastases in patients with gastric cancer. J Clin Oncol 14:1810-1817, 1996
20. Thorban S, Roder JD, Pantel K, et al: Epithelial tumour cells in bone marrow of patients with pancreatic carcinoma detected by immunocytochemical staining. Eur J Cancer 32A:363-365, 1996
21. Thorban S, Roder JD, Nekarda H, et al: Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal cancer. J Natl Cancer Inst 88:1222-1227, 1996
22. Pantel K, Aignherr C, Köllermann J, et al: Immunocytochemical detection of isolated tumour cells in bone marrow of patients with untreated stage C prostatic cancer. Eur J Cancer 31A:1627-1632, 1995
23. Maehara Y, Yamamoteo M, Oda S, et al: Cytokeratin-positive cells in bone marrow for identifying distant micrometastasis of gastric cancer. Br J Cancer 73:83-38, 1996
24. Funke I, Fries S, Heiss MM, et al: Comparative analyses of bone marrow micrometastases in breast and gastric cancer. Int J Cancer 65:755-761, 1996
25. Redding WH, Coombes RC, Monaghan P, et al: Detection of micrometastases in patients with primary breast cancer. Lancet 2:271-274, 1983
26. Pantel K, Izbicki JR, Angstwurm M, et al: Immunocytological detection of bone marrow micrometastases in operable small cell lung cancer. Cancer Res 53:1027-1031, 1993
27. Mansi JL, Berger U, Wilson P, et al: Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques. J Urol 139:545-548, 1988
28. Cote JR, Rosen PP, Hakes TB, et al: Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease. Am J Surg Pathol 12:333-340, 1988
29. Stahel RA, Mabry M, Skarin AT, et al: Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J Clin Oncol 3:455-461, 1985
30. Mansi JL, Berger U, Easton D, et al: Micrometastases in bone marrow in patients with primary breast cancer: Evaluation as an early predictor of bone metastases. Br Med J 295:1093-1096, 1987
31. Juhl H, Kalthoff H, Krüger U, et al: Immuncytologischer Nachweis disseminierter Tumorzellen in der Bauchhöhle und im Knochenmark von Pankreascarcinom-Patienten. Chirurg 65:1111-1115, 1994
32. Oberneder R, Riesenberg R, Kriegmair R, et al: Immunocytochemical detection and phenotypic characterization of micrometastatic tumour cells in bone marrow of patients with prostate cancer. Urol Res 22:3-8, 1994
33. Pantel K, Schlimok G, Angstwurm M , et al: Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 3:165-173, 1994
34. Riesenberg R, Oberneder R, Kriegmair M et al: Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumour cells. Histochemistry 99:61-66, 1993
35. Pantel K, Schlimok G, Kutter D, et al: Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells. Cancer Res 51:4712-4715, 1991
36. Menard S, Squicciarini P, Luini A, et al: Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features. Br J Cancer 69:1126-1129, 1994
37. Israeli RS, Miller WH, Su SL, et al: Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: Comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 54:6306-6310, 1994
38. Wood DP, Banks ER, Humphreys S, et al: Identification of bone marrow micrometastases in patients with prostate cancer. Cancer 74:2533-2540, 1994
39. Gerhard M, Juhl H, Kalthoff H, et al: Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 12:725-729, 1994
40. Datta YH, Adams PT, Drobyski, et al: Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12:475-482, 1994
41. Smith MR, Biggar S, Hussain M: Prostate-specific antigen messenger RNA is expressed in non-prostate cells. Implications for detection of micrometastases. Cancer Res 55:2630-2644, 1995
42. Neumaier M, Gerhard M, Wagener C: Diagnosis of micrometastases by the amplification of tissue-specific genes. Gene 159:43-47, 1995
43. 7. Proc Natl Acad Sci USA 92:537-541, 1995
44. O'Sullivan GC, Collins JK, O' Brien F, et al: Micrometastases in bone marrow of patients undergoing "curative" surgery for gastrointestinal cancer. Gastroenterology 109:1535-1540, 1995
45. Soeth E, Röder C, Juhl H, et al: The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of the disease. Int J Cancer 69:278-282, 1996
46. Deguchi T, Ehara H, Ito S, et al: Detection of micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer. Br J Cancer 75:634-638, 1997
47. Litle VR, Warren RS, Moore D, et al: Molecular cytogenetic analysis of cytokeratin 20-labelled cells in primary tumors and bone marrow aspirates from colorectal carcinoma patients. Cancer 79:1664-1670, 1997
48. Höchtlen-Vollmar W, Gruber R, Bodenmüller H, et al: Occult epithelial cells detected in bone marrow by an enzyme immunoassay specific for cytokeratin 19. Int J Cancer 70:396-400, 1997
49. Hermanek P: pTNM and residual tumor classifications: problems of assessment and prognostic significance. World J Surg 19:184-190, 1995
50. Robins JM, Greenland S: Mantel-Haenszel general estimate of the variance. Am J Epidemiol 124:719-723, 1986
51. Breslow NE, Day NE: The design and analyses of cohort studies, in Statistical Methods in Cancer Research (vol 2). Lyon, France, International Agency for Cancer Research Scientific Publications, 1987, pp 1-406
52. Cox DR: Regression models and life tables. J R Stat Soc 34:187-220, 1972
53. Sloane JP, Ormerod MG: Distribution of epithelial membrane antigen in normal and neoplastic tissues and its value in diagnostic tumor pathology. Cancer 47:1786-1795, 1981
54. Debus E, Weber K, Osborne M: Monoclonal cytokeratin antibodies that distinguish simple from stratified squamous epithelia. EMBO J 1:1641-1647, 1982
55. Debus E, Moll R, Franke WW: Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. Am J Pathol 114:121-126, 1984
56. Dearnaley DP, Ormerod MG, Sloane JP, et al: Detection of isolated mammary carcinoma cells in marrow of patients with primary breast cancer. J R Soc Med 766:359-364, 1983
57. Coombes RC, Dearnaley DP, Buckman R, et al: Detection of bone metastases in patients with breast cancer. Invasion Metastasis 2:177-184, 1982
58. Dearnaley DP, Sloane JP, Ormerod MG, et al: Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br J Cancer 44:85-90, 1981
59. Pantel K, Felber E, Schlimok G: Detection and characterization of residual disease in breast cancer. J Hematother 3:315-322, 1994
60. Pantel K, Koprowski H, Riethmüller G: Meeting report: Conference on Cancer Micrometastasis: Biology, methodology and clinical significance. Int J Oncol 3:1019-1022, 1993
61. Schlimok G, Riethmüller, G: Detection, characterization and tumorigenicity of tumor cells in human bone marrow. Semin Cancer Biol 1:207-215, 1990
62. Papac RJ: Bone marrow metastases. Cancer 74:2403-2413, 1994
63. Schlimok G, Riethmüller G: Monoclonal antibodies in the therapy of minimally residual solid tumors. Onkologie 18:403-408, 1995
64. Riethmüller G, Johnson JP: Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers. Curr Opin Immunol 4:647-655, 1992
65. Pantel K, Riethmüller G: Methods for detection of micrometastatic carcinoma cells in bone marrow, blood and lymph nodes. Onkologie 18:394-401, 1995
66. Jauch KW, Fries S, Grützner U, et al: Prognostic significance of 'micrometastases'. Onkologie 18:525-532, 1995
67. Neville AM: Functional immunocytopathology and the diagnosis of bone marrow micrometastases. Cytopathology 1:223-231, 1990
68. Neville AM: The detection and prognostic significance of micrometastases. J Clin Immunoassay 14:160-163, 1991
69. Osborne MP, Rosen PP: Detection and management of bone marrow micrometastases in breast cancer. Oncology 8:25-29, 1994
70. Pecorini F, Veneziano M, Framrino Dei Malatesta ML, et al: Considerations on the prognostic significance of bone marrow micrometastases in breast cancer. Eur J Gynaecol Oncol 14:501-505, 1993
71. Porro G, Menard S, Tagliabue E, et al: Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients. Cancer 61:2407-2411, 1988
72. Schlimok G, Funke I, Holzmann B, et al: Micrometastatic cancer cells in bone marrow: In vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc Natl Acad Sci USA 84:8672-8676, 1987
73. Pantel K, Schlimok G, Angstwurm M, et al: Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 3:165-173, 1994
74. Thor A, Viglione MJ, Ohuchi N, et al: Comparison of monoclonal antibodies for the detection of occult breast carcinoma metastases in bone marrow. Breast Cancer Res Treat 11:133-145, 1988
75. Manegold C, Krempin B, Kaufmann M, et al: The value of bone marrow examination for tumor staging in breast cancer. J Cancer Res Clin Oncol 114:425-428, 1988
76. Courtemanche DJ, Worth AJ, Coupland RW, et al: Detection of micrometastases from primary breast cancer. Can J Surg 34:15-19, 1991
77. Taha M, Ordonez NG, Kulkarni S, et al: A monoclonal antibody cocktail for detection of micrometastatic tumor cells in the bone marrow of breast cancer patients. Bone Marrow Transplant 4:297-303, 1989
78. Giai M, Natoli C, Sismondi P, et al: Bone marrow micrometastases detected by a monoclonal antibody in patients with breast cancer. Anticancer Res 10:119-122, 1990
79. Juhl H, Stritzel M, Wroblewski A, et al: Immunocytological detection of micrometastatic cells: Comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 57:330-335, 1994
80. Ellis G, Ferguson M, Yamanaka E, et al: Monoclonal antibodies for detection of occult carcinoma cells in bone marrow of breast cancer cells. Cancer 63:2509-2514, 1989
81. Frew AJ, Ralfkiaer N, Gosh AK, et al: Immunocytochemistry in the detection of bone marrow metastases in patients with primary lung cancer. Br J Cancer 53:555-556, 1986
82. Gosh AK, Erber WN, Hatton CRS, et al: Detection of metastatic tumour cells in routine bone marrow smears by immuno-alkaline phosphatase labelling with monoclonal antibodies. Br J Hematother 61:21-30, 1985
83. Canon JL, Humblet Y, Lebaq-Verheyden AM, et al: Immunodetection of small cell lung cancer metastases in bone marrow using three monoclonal antibodies. Eur J Cancer Clin Oncol 24:147-150, 1988
84. Shpall EJ, Jones RB: Release of tumor cells from bone marrow. Blood 83:623-625, 1994
85. Passos-Coelho J, Ross AA, Davis JM, et al: Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: Effect of ex vivo purging with 4-hydroyperoxycyclophosphamide. Cancer Res 54:2366-2371, 1994
86. Hay FG, Ford A, Leonard RCF: Clinical applications of immunocytochemistry in the monitoring of the bone marrow in small cell lung cancer (SCLC). Int J Cancer 2:8-10, 1988
87. Leonard RCF, Duncan LW, Hay FG: Immunocytological detection of residual marrow disease at clinical remission predicts metastatic relapse in small cell lung cancer. Cancer Res 50:6545-6548, 1990
88. Funke I, Fries S, Jauch KW: Tumorzellnachweis im Knochenmark: Entscheidungshilfe zur adjuvanten Therapie bei nodal-negativen Patientinnen mit Mammakarzinom. Chirurg 62:805-809, 1991
89. Schlimok G, Pantel K, Loibner H, et al: Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: Towards a novel surrogate test to monitor adjuvant therapies of solid tumours. Eur J Cancer 31A:1799-1803, 1995
90. Fielding LP, Henson DE: Multiple prognostic factors and outcome analysis in patients with cancer. Cancer 71:2426-2429, 1993
91. Parmar MKB, Stewart LA, Altman DG: Meta-analyses of randomised trials: When the whole is more than just the sum of the parts. Br J Cancer 74:496-501, 1994
92. Funke I, Schlimok G. Bock B, et al: Diagnosis and treatment of early micrometastasis of human carcinomas: Challenges and chances for monoclonal antibodies, in Albertini A (ed): Molecular Probes. Technology and Medical Applications. New York NY, Raven, 1989, pp 237-244
93. Pantel K, Schlimok G, Braun S, et al: Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 85:1419-1424, 1993
94. Diel IJ, Kaufmann M, Goerner R, et al: Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastases. J Clin Oncol 10:1534-1539, 1992
95. Heiss MM, Allgayer H, Gruetzner U, et al: Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancer. Nature Med 1:1035-1039, 1995
96. Allgayer H, Heiss MM, Riesenberg R, et al: Urokinase plasminogen activator receptor (uPA-R): One potential characteristic of metastatic phenotypes in minimal residual tumor disease. Cancer Res 57:1394-1399, 1997
97. O'Sullivan GCO, Collins JK, Kelly J, et al: Micrometastases: Marker of metastatic potential or evidence of residual disease. Gut 40:512-515, 1997
98. Mansi JL, Berger U, McDonell T, et al: The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol 7:445-449, 1939
99. Osborne MP, Asina S, Wong GY, et al: Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: Sensitivity in a model system. Cancer Res 49:2510-2513, 1989
100. Osborne MP, Wong GY, Asina S et al: Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow. Cancer Res 51:2706-2709, 1991